Showing results (81-90 of 298) with videos related to

Sort By:
Pageof 30
Mycoses|April 5, 2020
Posaconazole delayed-release tablets in paediatric haematology-oncology patientsMargherita Mauro, Antonella Colombini, Katia Perruccio, et al.
Pediatric Blood & Cancer|December 13, 2006
Results of a multicenter retrospective study of a combined medical and surgical approach to pulmonary aspergillosis in pediatric neutropenic patientsSimone Cesaro, Giovanni Cecchetto, Federica De Corti, et al.
Human Mutation|January 10, 2018
Somatic mutations activating Wiskott-Aldrich syndrome protein concomitant with RAS pathway mutations in juvenile myelomonocytic leukemia patientsAlessandro Coppe, Leonardo Nogara, Matteo Samuele Pizzuto, et al.
Pediatric Blood & Cancer|January 20, 2018
Venoocclusive disease due to chemotherapy for pediatric acute lymphoblastic leukemia is associated with increased levels of plasminogen-activator inhibitor-1Margherita Mauro, Graziella Saggiorato, Maria Teresa Sartori, et al.
Blood Reviews|September 30, 2016
Risk stratification for invasive fungal infections in patients with hematological malignancies: SEIFEM recommendationsLivio Pagano, Alessandro Busca, Anna Candoni, et al.
The Lancet. Infectious Diseases|February 13, 2019
Vaccination of haemopoietic stem cell transplant recipients: guidelines of the 2017 European Conference on Infections in Leukaemia (ECIL 7)Catherine Cordonnier, Sigrun Einarsdottir, Simone Cesaro, et al.
European Journal of Haematology|December 15, 2017
Posaconazole oral dose and plasma levels in pediatric hematology-oncology patientsEdoardo Bruno Vicenzi, Elisabetta Calore, Nunzia Decembrino, et al.
American Journal of Hematology|January 30, 2003
Successful engraftment and stable full donor chimerism after myeloablation with thiotepa, fludarabine, and melphalan and CD34-selected peripheral allogeneic stem cell transplantation in hemophagocytic lymphohistiocytosisSimone Cesaro, Maria Vittoria Gazzola, Piero Marson, et al.
Biology of Blood and Marrow Transplantation : Journal of the American Society for Blood and Marrow Transplantation|May 20, 2009
Early (day -7) versus conventional (day -1) inception of cyclosporine-A for graft-versus-host disease prophylaxis after unrelated donor hematopoietic stem cell transplantation in children. Long-term results of an AIEOP prospective, randomized studyEdoardo Lanino, Roberto Rondelli, Franco Locatelli, et al.
Mediterranean Journal of Hematology and Infectious Diseases|November 16, 2020
The Diagnostic Pitfalls of MucormycosisMargherita Mauro, Giuliana Lo Cascio, Rita Balter, et al.
Pageof 30